Epigenomics, Biopsytec cross-licensing deal

Epigenomics (Berlin, Germany) obtained exclusive rights to use Identification of Linkage Disequilibrium (ILD) technology from Biopsytec (Berlin, Germany) in pharmaceutical research and diagnostics. In...